early Alzheimer's disease

Amyloid-related imaging abnormalities (ARIA) found in approximately 40% of patients taking “Alzheimer’s drug” Aduhelm

November 29, 2021 by SharpBrains

Study: Biogen’s Aduhelm Caused Brain Swelling in Over One-Third of Study Participants (BioSpace):

Attention is being focused on a side effect of Biogen’s Alzheimer’s drug, Aduhelm (aducanumab). Even before its controversial approval on June 7, there were cases of amyloid-related imaging abnormalities (ARIA‑E), or cerebral edema, observed in the trials. [Read more…] about Amyloid-related imaging abnormalities (ARIA) found in approximately 40% of patients taking “Alzheimer’s drug” Aduhelm

Diagnosing early Alzheimer’s and Mild Cognitive Impairment: Emerging Challenges and Implications

February 7, 2012 by SharpBrains

Blurry line in diagnosing early Alzheimer’s: study (Reuters):

“The revised definition of a brain condition called mild cognitive impairment means that many people now considered to have mild or early Alzheimer’s disease could easily be given that diagnosis instead, suggests a new study.” [Read more…] about Diagnosing early Alzheimer’s and Mild Cognitive Impairment: Emerging Challenges and Implications